Home Public Health Protocol for Using Bamlanivimab + Etesevimab Anti-SARC-CoVID-2 Monoclonal Antibodies

Protocol for Using Bamlanivimab + Etesevimab Anti-SARC-CoVID-2 Monoclonal Antibodies

by Public Health Update

The Bamlanivimab+Etesevimab are anti-SARC-COVID-2 monoclonal antibodies which have received Emergency Use Authorization (EUA) from US FDA as well as conditional use approval from the MoHP, Department of Drug Administration (DDA) in Nepal.


Latest Posts

Thanks for visiting us.
Disclaimer: The resources, documents, guidelines, and information on this blog have been collected from various sources and are intended for informational purposes only. Information published on or through this website and affiliated social media channels does not represent the intention, plan, or strategies of an organization that the initiator associated with in professional or personal capacity, unless explicitly indicated.

If you have any complaints, information, or suggestions about the content published on Public Health Update, please feel free to contact at blog.publichealthupdate@gmail.com.

You may also like

Public Health Update (Sagun’s Blog) is a popular public health portal in Nepal. Thousands of health professionals are connected with Public Health Update to get up-to-date public health updates, search Jobs and explore opportunities.

#1 Public Health Blog for sharing Job opportunities and updates in Nepal

Public Health Initiative, A Registered Non-profit organization – All Right Reserved. 2011-2023